Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era

Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era Publisher Pubmed

Azimi SZ¹ ; Firooz A¹ ; Murrell DF² ; Daneshpazhooh M³

Source: Dermatologic Therapy Published:2020

Abstract

Bullous pemphigoid (BP) is the most common autoimmune blistering disease with subepidermal involvement, typically affecting the elderly. It has spontaneous remissions and exacerbations with significant morbidity. A novel coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the new universal coronavirus disease 2019 (COVID-19) pandemic. The pandemic made concerns, especially about immunosuppressive therapy. In this article, we reviewed the management of BP in the COVID-19 pandemic era. The data about the best management of autoimmune bullous diseases like BP, during the outbreak of COVID-19, are evolving and updated every day. © 2020 Wiley Periodicals LLC.

Related Docs

View other Related Docs

1. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)

2. Cardiovascular Complications of Covid-19: Pharmacotherapy Perspective, Cardiovascular Drugs and Therapy (2021)

3. Covid-19: Review of a 21St Century Pandemic From Etiology to Neuro-Psychiatric Implications, Journal of Alzheimer's Disease (2020)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (2)

Zeinab Aryanian (1)

Style	Citing Format
MLA	Azimi SZ, et al.. "Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era." Dermatologic Therapy, vol. 33, no. 6, 2020, pp. -.
APA	Azimi SZ, Firooz A, Murrell DF, Daneshpazhooh M (2020). Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era. Dermatologic Therapy, 33(6), -.
Chicago	Azimi SZ, Firooz A, Murrell DF, Daneshpazhooh M. "Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era." Dermatologic Therapy 33, no. 6 (2020): -.
Harvard	Azimi SZ et al. (2020) 'Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era', Dermatologic Therapy, 33(6), pp. -.
Vancouver	Azimi SZ, Firooz A, Murrell DF, Daneshpazhooh M. Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era. Dermatologic Therapy. 2020;33(6):-.
BibTex	@article{ author = {Azimi SZ and Firooz A and Murrell DF and Daneshpazhooh M}, title = {Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era}, journal = {Dermatologic Therapy}, volume = {33}, number = {6}, pages = {-}, year = {2020} }
RIS	TY - JOUR AU - Azimi SZ AU - Firooz A AU - Murrell DF AU - Daneshpazhooh M TI - Treatment Concerns for Bullous Pemphigoid in the Covid-19 Pandemic Era JO - Dermatologic Therapy VL - 33 IS - 6 SP - EP - PY - 2020 ER -

Science Communicator Platform

Authors

Abstract